---
title: "Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286411139.md"
description: "Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update."
datetime: "2026-05-14T11:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286411139.md)
  - [en](https://longbridge.com/en/news/286411139.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286411139.md)
---

# Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update.

### Related Stocks

- [BFRI.US](https://longbridge.com/en/quote/BFRI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BFRIW.US](https://longbridge.com/en/quote/BFRIW.US.md)

## Related News & Research

- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md)
- [Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research](https://longbridge.com/en/news/286996626.md)
- [Cognition Therapeutics plans late-stage zervimesine trial for Lewy body dementia psychosis](https://longbridge.com/en/news/287210806.md)